TP53 and endometrial carcinoma: Using sequential forward selection, we built subtype classification models for the molecular subtypes of endometrial carcinoma, comprising 5 miRNAs for MMR-deficient tumors and 10 miRNAs for p53 mutated tumors, with AUCs of 0.75 and 0.85, respectively (Figure 5).